Skip to content

Study of the effect of Lavender and Cuscuta extract in depression

Study of the effect of oral Cuscuta and Lavender intreatment of patients with depression admitted in hospitals of Shiraz University of Medical Sciences in 1390:A randomized controlled trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201108177357N1
Enrollment
171
Registered
2011-11-13
Start date
2011-08-27
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression. Depressive episode

Interventions

Intervention 1: Interventional group1: Lavender,400 mg capsules,BID for 8 weeks. Intervention 2: Control group: common anti-depressive drugs. Intervention 3: Intervention group 2: Cuscuta, 500 mg caps
Treatment - Drugs
Interventional group1: Lavender,400 mg capsules,BID for 8 weeks
Control group: common anti-depressive drugs
Intervention group 2: Cuscuta, 500 mg capsules,QID for 8 weeks

Sponsors

Research Center for Traditional Medicine and History of Medicine- Vice-Chancellery of Research and T
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: all patients with the diagnosis of depression confirmed with at least 2 independent psychiatrists based on Hamilton and Becks criteria and DMS IV hospitalized in the educational hospitals. Exclusion criteria: patients who may have other underlying disorders(medical or psychiatric); addicted patients; pregnant women and patients who may need ECT

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Beck's score. Timepoint: Before intervention and after 8 weeks. Method of measurement: Standardized Beck's questionnaire.;Hamilton's score. Timepoint: Before intervention and after 8 weeks. Method of measurement: Standardized Hamilton's questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaye Jahanbin

Shiraz medical school

bgs_2986@yahoo.com+98 71 1233 7589

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026